[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

IL71239A - Pharmaceutical composition containing oligosaccharide derivatives for treatment or prophylaxis of pneumococcus infections - Google Patents

Pharmaceutical composition containing oligosaccharide derivatives for treatment or prophylaxis of pneumococcus infections

Info

Publication number
IL71239A
IL71239A IL71239A IL7123984A IL71239A IL 71239 A IL71239 A IL 71239A IL 71239 A IL71239 A IL 71239A IL 7123984 A IL7123984 A IL 7123984A IL 71239 A IL71239 A IL 71239A
Authority
IL
Israel
Prior art keywords
treatment
residue
hydrogen
compounds
prophylaxis
Prior art date
Application number
IL71239A
Other languages
English (en)
Other versions
IL71239A0 (en
Original Assignee
Carbohydrates Int Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Carbohydrates Int Ab filed Critical Carbohydrates Int Ab
Publication of IL71239A0 publication Critical patent/IL71239A0/xx
Priority to IL102583A priority Critical patent/IL102583A0/xx
Priority to IL102584A priority patent/IL102584A0/xx
Priority to IL102589A priority patent/IL102589A0/xx
Priority to IL103012A priority patent/IL103012A0/xx
Publication of IL71239A publication Critical patent/IL71239A/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Socks And Pantyhose (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Fats And Perfumes (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL71239A 1983-03-23 1984-03-14 Pharmaceutical composition containing oligosaccharide derivatives for treatment or prophylaxis of pneumococcus infections IL71239A (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
IL102583A IL102583A0 (en) 1983-03-23 1992-07-21 Oligosaccharide derivative
IL102584A IL102584A0 (en) 1983-03-23 1992-07-21 Oligosaccharide derivative
IL102589A IL102589A0 (en) 1983-03-23 1992-07-21 Oligosaccharide derivative
IL103012A IL103012A0 (en) 1983-03-23 1992-09-01 Pharmaceutical and diagnostic compositions containing oligosaccharide derivatives coupled to a macromolecular carrier

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8301609A SE8301609D0 (sv) 1983-03-23 1983-03-23 Forening och komposition for terapeutisk eller diagnostisk anvendning jemte forfarande for terapeutisk behandling

Publications (2)

Publication Number Publication Date
IL71239A0 IL71239A0 (en) 1984-06-29
IL71239A true IL71239A (en) 1993-05-13

Family

ID=20350499

Family Applications (1)

Application Number Title Priority Date Filing Date
IL71239A IL71239A (en) 1983-03-23 1984-03-14 Pharmaceutical composition containing oligosaccharide derivatives for treatment or prophylaxis of pneumococcus infections

Country Status (10)

Country Link
EP (1) EP0126043B1 (xx)
JP (1) JPS59176300A (xx)
AT (1) ATE47595T1 (xx)
AU (1) AU566286B2 (xx)
DE (1) DE3480288D1 (xx)
DK (1) DK160484A (xx)
FI (1) FI841161A (xx)
IL (1) IL71239A (xx)
NO (1) NO163656C (xx)
SE (1) SE8301609D0 (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2564468B1 (fr) * 1984-05-16 1994-12-23 Choay Sa Nouveaux oligosaccharides, leur preparation par voie de synthese et leurs applications biologiques
DK17685D0 (da) * 1985-01-14 1985-01-14 Hans Goeran Magnusson Glycosidderivater
SE8501613D0 (sv) * 1985-04-01 1985-04-01 Bio Carb Ab Foreningar for terapeutisk eller diagnostisk anvendning jemte forfarande for terapeutisk behandling
EP0287029A2 (de) * 1987-04-14 1988-10-19 Pulverer, Gerhard, Prof. Dr.Dr.h.c. Verwendung von Monosacchariden und/oder diese Monosaccharide enthaltenden Glykokonjugaten zur Behandlung von Infektionen durch Krankheitserreger
SE463314B (sv) * 1989-03-01 1990-11-05 Biocarb Ab Sampolymerer av en n-acylerad glykosylamin och en amid, n-akryloyl-eller metakryloylglykosylaminer samt foerfarande foer framstaellning av dessa
EP0553113B1 (en) * 1990-08-02 1998-11-25 Antex Biologics, Inc. Adhesion receptors for pathogenic or opportunistic microorganisms
SE469256B (sv) * 1991-02-18 1993-06-14 Medscand Ab Rengoeringsprodukt
US5718909A (en) * 1991-02-18 1998-02-17 Medscand Ab Sheet containing carbohydrate derivative for removal of E. coli
EP0563795B1 (en) * 1992-03-31 1998-07-22 Dai Nippon Printing Co., Ltd. Enzyme-immobilized electrode, composition for preparation of the same and electrically conductive enzyme
US5401723A (en) * 1992-12-02 1995-03-28 Colgate-Palmolive Company Glycoconjugate inhibition of Streptococcus pyrogenes adhesion
US5514665A (en) * 1993-12-30 1996-05-07 University Of British Columbia Method of preventing or reducing the risk of infection by bacterial pathogens utilizing simple and conjugated dextrans
US5665561A (en) * 1994-06-06 1997-09-09 The Rockefeller University Modulators of pneumococcal adherence to pulmonary and vascular cells and diagnostic and therapeutic applications
US5736533A (en) * 1995-06-07 1998-04-07 Neose Technologies, Inc. Bacterial inhibition with an oligosaccharide compound
US6737524B2 (en) 2002-03-25 2004-05-18 Paul K. Smith Activated polyethylene glycol compounds
US7144989B2 (en) 2002-03-25 2006-12-05 Albert Einstein College Of Medicine Of Yeshiva University Pegylated non-hypertensive hemoglobins, methods of preparing same, and uses thereof
PL1629850T5 (pl) 2004-08-24 2013-09-30 Nutricia Nv Kompozycja odżywcza zawierająca niestrawne transgalaktooligosacharydy i strawne galaktozosacharydy

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4324887A (en) * 1978-08-16 1982-04-13 President And Fellows Of Harvard College Type II group B Streptococci polysaccharide
SE8000658L (sv) * 1980-01-28 1981-07-29 Sigfried Edvin Svensson Isolering av kolhydrater ur cellvevnad
SE8001748L (sv) * 1980-03-05 1981-09-06 Kaellenius Gunilla Kompositioner for terapeutisk eller diagnostisk anvendning jemte forfarande for terapeutik
EP0058665B1 (en) * 1980-05-09 1986-02-26 LEFFLER, Hakon Carbohydrate derivatives for inhibiting bacterial adherence
AU561066B2 (en) * 1982-03-22 1987-04-30 Biocarb Ab Antibacterial composition containing an oligosaccharide
DK131083A (da) * 1982-03-23 1983-09-24 Svenska Sockerfabriks Ab Fremgangsmaade til fremstilling af terapeutiske eller diagnostiske praeparater

Also Published As

Publication number Publication date
JPS59176300A (ja) 1984-10-05
EP0126043A1 (en) 1984-11-21
ATE47595T1 (de) 1989-11-15
AU2587184A (en) 1984-09-27
DK160484A (da) 1984-09-24
NO163656B (no) 1990-03-19
IL71239A0 (en) 1984-06-29
DE3480288D1 (en) 1989-11-30
AU566286B2 (en) 1987-10-15
DK160484D0 (da) 1984-03-20
SE8301609D0 (sv) 1983-03-23
NO841135L (no) 1984-09-24
FI841161A (fi) 1984-09-24
FI841161A0 (fi) 1984-03-22
NO163656C (no) 1990-06-27
EP0126043B1 (en) 1989-10-25

Similar Documents

Publication Publication Date Title
IL71239A (en) Pharmaceutical composition containing oligosaccharide derivatives for treatment or prophylaxis of pneumococcus infections
DE3881246D1 (de) Durch benzhydryl n-substituierte heterocyclische derivate, ihre herstellung und ihre verwendung.
ZA82567B (en) Process for the preparation of 2-penem compounds,novel 2-penem compounds produced thereby,and pharmaceutical compositions containing them
DE69120500D1 (de) Azasteroide zur Behandlung prostatischer Hypertrophie, ihre Herstellung und Verwendung
BG100951A (en) Novel erythromycin derivatives, method for their preparation and their use as drugs
NO900807L (no) Nye organiske forbindelser og fremgangsmaate for fremstilling derav.
DE3475302D1 (en) Carbacyclins, process for their manufacture and their use as pharmaceutical compounds
HUT50337A (en) Process for producing benzoxazine derivatives and pharmaceutical compositions comprising the compounds
PT91607A (pt) Process for the preparation of substituted beta-diketones and of pharmaceutical compositions containing them
DK45987D0 (da) Thianaphthenderivater, deres fremstilling og anvendelse
AU608643B2 (en) Novel derivatives of the oxime of 1,2,5,6-tetrahydropyridin-3-carboxaldehyde, the process for their preparation, their use as medicaments and the compositions containing them
ATE70842T1 (de) Bakterizide pyridobenzothiazinderivate mit langer wirkungsdauer.
ES2054829T3 (es) Antibioticos del grupo mureidomicina, su preparacion y su empleo.
HUT54688A (en) Process for producing compounds utilizable for treating ulcus and pharmaceutical compositions containing them as active components
YU150690A (sh) Benzotiazinski derivati i postupak za njihovo dobijanje
DK41190A (da) Hidtil ukendte organiske forbindelser og fremgangsmaade til fremstilling deraf
TH10969EX (th) อนุพันธ์เบนซิไซไธโออะโวลิโนน-1-ไดออกไซด์ในรูปสารยับยั้งเอนไซม์อีลาสเทส
PT84067A (en) Novel pregnane derivatives process for their preparation and pharmaceutical compositions containing same